Neo Lithium Corp (NLC.CA) Fundamental Analysis & Valuation

TSX-V:NLC

Current stock price

6.5
+0.01 (+0.15%)
Last:

This NLC.CA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. NLC.CA Profitability Analysis

1.1 Basic Checks

  • In the past year NLC was profitable.
NLC.CA Yearly Net Income VS EBIT VS OCF VS FCFNLC.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 0 10M -10M

1.2 Ratios

Industry RankSector Rank
ROA 17.96%
ROE 18.43%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
NLC.CA Yearly ROA, ROE, ROICNLC.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 0 -20 -40 -60

1.3 Margins

  • NLC does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
NLC.CA Yearly Profit, Operating, Gross MarginsNLC.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020

6

2. NLC.CA Health Analysis

2.1 Basic Checks

  • NLC has more shares outstanding than it did 1 year ago.
  • NLC has a better debt/assets ratio than last year.
NLC.CA Yearly Shares OutstandingNLC.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 20M 40M 60M 80M 100M
NLC.CA Yearly Total Debt VS Total AssetsNLC.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 20M 40M 60M

2.2 Solvency

  • An Altman-Z score of 201.84 indicates that NLC is not in any danger for bankruptcy at the moment.
  • NLC has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 201.84
ROIC/WACCN/A
WACCN/A
NLC.CA Yearly LT Debt VS Equity VS FCFNLC.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 0 20M 40M 60M

2.3 Liquidity

  • A Current Ratio of 20.31 indicates that NLC has no problem at all paying its short term obligations.
  • NLC has a Quick Ratio of 20.31. This indicates that NLC is financially healthy and has no problem in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 20.31
Quick Ratio 20.31
NLC.CA Yearly Current Assets VS Current LiabilitesNLC.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 20M 40M 60M

4

3. NLC.CA Growth Analysis

3.1 Past

  • NLC shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 821.16%, which is quite impressive.
  • NLC shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 342.91% yearly.
EPS 1Y (TTM)821.16%
EPS 3Y342.91%
EPS 5YN/A
EPS Q2Q%357.22%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • The Earnings Per Share is expected to grow by 140.75% on average over the next years. This is a very strong growth
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-25%
EPS Next 2Y-11.8%
EPS Next 3Y146.62%
EPS Next 5Y140.75%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
NLC.CA Yearly Revenue VS EstimatesNLC.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2023 2024 2025 20M 40M 60M
NLC.CA Yearly EPS VS EstimatesNLC.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1 2 3

1

4. NLC.CA Valuation Analysis

4.1 Price/Earnings Ratio

  • NLC is valuated quite expensively with a Price/Earnings ratio of 40.63.
  • NLC is valuated rather expensively when we compare the Price/Earnings ratio to 27.18, which is the current average of the S&P500 Index.
  • The Forward Price/Earnings Ratio is negative for NLC. No positive earnings are expected for the next year.
Industry RankSector Rank
PE 40.63
Fwd PE N/A
NLC.CA Price Earnings VS Forward Price EarningsNLC.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 -50 -100

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA -91.79
NLC.CA Per share dataNLC.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 0.4 0.6

4.3 Compensation for Growth

  • NLC's earnings are expected to grow with 146.62% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-11.8%
EPS Next 3Y146.62%

0

5. NLC.CA Dividend Analysis

5.1 Amount

  • NLC does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

NLC.CA Fundamentals: All Metrics, Ratios and Statistics

Neo Lithium Corp

TSX-V:NLC (1/31/2022, 7:00:00 PM)

6.5

+0.01 (+0.15%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)N/A
Earnings (Next)N/A
Inst Owners14.1%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap919.17M
Revenue(TTM)N/A
Net Income(TTM)19.58M
Analysts81.54
Price Target6.78 (4.31%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 40.63
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 8.65
P/tB N/A
EV/EBITDA -91.79
EPS(TTM)0.16
EY2.46%
EPS(NY)-0.05
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0
BVpS0.75
TBVpSN/A
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 17.96%
ROE 18.43%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y0%
ROICexgc growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 20.31
Quick Ratio 20.31
Altman-Z 201.84
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)821.16%
EPS 3Y342.91%
EPS 5YN/A
EPS Q2Q%357.22%
EPS Next Y-25%
EPS Next 2Y-11.8%
EPS Next 3Y146.62%
EPS Next 5Y140.75%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A

Neo Lithium Corp / NLC.CA Fundamental Analysis FAQ

What is the ChartMill fundamental rating of Neo Lithium Corp (NLC.CA) stock?

ChartMill assigns a fundamental rating of 5 / 10 to NLC.CA.


What is the valuation status for NLC stock?

ChartMill assigns a valuation rating of 3 / 10 to Neo Lithium Corp (NLC.CA). This can be considered as Overvalued.


Can you provide the profitability details for Neo Lithium Corp?

Neo Lithium Corp (NLC.CA) has a profitability rating of 5 / 10.


Can you provide the PE and PB ratios for NLC stock?

The Price/Earnings (PE) ratio for Neo Lithium Corp (NLC.CA) is 40.63 and the Price/Book (PB) ratio is 8.65.


How financially healthy is Neo Lithium Corp?

The financial health rating of Neo Lithium Corp (NLC.CA) is 8 / 10.